Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FavId immunotherapy in follicular B-cell lymphoma
NCT00036426Phase 2Unknown
- Sponsor
- Favrille, Inc.
- Start
- Mar 2001
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label trial of FavId in follicular lymphoma (FL), sponsored by Favrille, Inc. Status: unknown.
02
Drugs
FavId
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00036426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00036426.